Canopy Partners, LLC Amgen Inc Transaction History
Canopy Partners, LLC
- $215 Billion
- Q2 2024
A detailed history of Canopy Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Canopy Partners, LLC holds 2,561 shares of AMGN stock, worth $811,606. This represents 0.37% of its overall portfolio holdings.
Number of Shares
2,561
Previous 2,530
1.23%
Holding current value
$811,606
Previous $719 Million
11.24%
% of portfolio
0.37%
Previous 0.35%
Shares
3 transactions
Others Institutions Holding AMGN
# of Institutions
3,087Shares Held
417MCall Options Held
7.19MPut Options Held
6.13M-
Vanguard Group Inc Valley Forge, PA51.9MShares$16.4 Billion0.32% of portfolio
-
Black Rock Inc. New York, NY46MShares$14.6 Billion0.33% of portfolio
-
State Street Corp Boston, MA29MShares$9.18 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA14.4MShares$4.58 Billion3.32% of portfolio
-
Morgan Stanley New York, NY14.4MShares$4.55 Billion0.35% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $170B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...